IDXX

#328
Idexx Laboratories Inc
582.28 USD
+1.44%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
581.57
583.31
1年のレンジ
398.75
769.98
1日の変化
+1.44%
月次変化
-0.06%
6か月変化
-9.05%
1年の変化
+43.66%
以前の終値
574.00
始値
582.95
Bid
Ask
安値
581.57
High
583.31
ボリューム
130
チャート全体を表示

Financials

概要 明細書 統計
期次 年次
  • Market Capitalization 46.36 B
  • Employee 11 K
  • Founded 1983
  • CEO Jay Mazelsky
  • Website www.idexx.com
  • Headquarter Delaware, United States
  • FIGI BBG000BLRT07
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
51.72
売上高対価格比率
12.76

IDEXX Laboratories Inc

IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture, and distribution of products and services for the companion animal veterinary, livestock and poultry, water testing, and dairy markets. Incorporated in 1983 by David Evans Shaw, the company is headquartered in Westbrook, Maine, and in Hoofddorp, Netherlands for its EMEA divisions. IDEXX offers products to customers in over 175 countries around the world and employs approximately 9,200 people in full-and part-time positions. There are three main segments of the company: Companion Animal Group, Water, and Livestock, Poultry and Dairy. In addition, the company also manufactures and sells pet-side SNAP tests for a variety of animal health diagnostic uses. In 2002, Jon Ayers succeeded company founder Shaw as chairman and CEO. During Ayers 20-year tenure, the company's annual revenue grew from $380 million to $3 billion, raising share prices by more than 100 times. In 2019, Jay Mazelsky succeeded Ayers in the role of CEO.

ニュース